SRF Misses Q2 Estimates, Announces Strategic Pact With Chemours

SRF Ltd., a leading chemical and packaging films manufacturer, posted its Q2 FY26 results with both profit and revenue falling short of analyst expectations. Alongside the earnings report, SRF revealed a strategic partnership with The Chemours Company to expand its fluoropolymer and fluoroelastomer capacity in India, reinforcing its global supply chain footprint.

Key highlights  

• Consolidated net profit for Q2 stood at ₹3.88 billion, below the IBES estimate of ₹4.3 billion  
• Total revenue from operations reached ₹36.4 billion, missing the ₹39.22 billion forecast  
• The company attributed the miss to margin pressures and subdued demand in key segments  
• SRF will invest ₹7.45 billion to support the strategic agreement with Chemours  
• The partnership aims to meet rising global demand for advanced performance materials by 2026  
• Chemours gains access to SRF’s manufacturing capabilities in India, enhancing operational flexibility  
• The agreement strengthens SRF’s position in the specialty chemicals segment, especially in thermal and specialized solutions

Notable updates  

• SRF continues to focus on capex-led growth and product innovation  
• Analysts expect the Chemours deal to drive long-term value despite near-term earnings softness  
• No interim dividend was declared for the quarter

SRF’s Q2 performance reflects short-term headwinds, but its strategic alignment with Chemours signals a forward-looking approach to global market expansion.

Sources: SRF Ltd. press release, Chemours official website, StreetInsider, Reuters, Moneycontrol